Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M577Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-5.4
Enterprise Value $M24.1EPS (TTM) $-0.4Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)--Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio8.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-4.8Current Ratio8.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.5Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)-41.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M95.0ROIC % (ttm)-133.2Gross Margin Increase y-yN

Gurus Latest Trades with CASC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CASC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myers Scott DunsethPresident and CEO 2016-06-28Buy62,500$0.820view
Venkatesan JayEVP and General Manager 2014-09-23Buy250,000$2-52view
BVF PARTNERS L P/IL10% Owner 2013-11-01Buy129,000$1.78-46.07view
BVF PARTNERS L P/IL10% Owner 2013-08-08Buy258,361$1.65-41.82view
BVF PARTNERS L P/IL10% Owner 2013-08-01Buy338,087$1.74-44.83view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy214,467$1.81-46.96view
Ayer Capital Management, LP10% Owner 2011-06-23Sell28,900$8.74-89.02view
Karan Shashi K.Corporate Controller 2010-09-28Buy5,100$3.41-71.85view
Karan Shashi K.Corporate Controller 2009-08-18Buy5,000$5.07-81.07view

Quarterly/Annual Reports about CASC:

    News about CASC:

    Articles On GuruFocus.com
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 

    More From Other Websites
    Cascadian Therapeutics Receives ONT-380 Fast Track Designation from FDA for the Treatment of... Jun 29 2016
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 29 2016
    8:02 am Cascadian Therapeutics receives ONT-380 Fast Track designation from FDA for the treatment of... Jun 29 2016
    Cascadian Therapeutics Receives ONT-380 Fast Track Designation from FDA for the Treatment of... Jun 29 2016
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 28 2016
    Cascadian Therapeutics Announces Exercise of Underwriters' Over-Allotment Option and Closing of... Jun 28 2016
    Cascadian Therapeutics (CASC) Jumps: Stock Rises 10.4% Jun 24 2016
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jun 23 2016
    Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common Stock and Series D... Jun 23 2016
    Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common Stock and Series D... Jun 23 2016
    Cascadian Therapeutics Announces Proposed Public Offering Jun 22 2016
    Cascadian Therapeutics Announces Proposed Public Offering Jun 22 2016
    Biotech Stock Mailbag: Cascadian Therapeutics, Global Blood Therapeutics, Bad Favus Jun 20 2016
    CASCADIAN THERAPEUTICS, INC. Financials Jun 16 2016
    Cascadian Therapeutics (Nasdaq: CASC) to Ring The Nasdaq Stock Market Closing Bell Jun 14 2016
    Cascadian Therapeutics (Nasdaq: CASC) to Ring The Nasdaq Stock Market Closing Bell Jun 14 2016
    Cascadian Therapeutics Reports Topline ONT-380 "Triplet" Data and Outlines Key Development... Jun 14 2016
    CASCADIAN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 14 2016
    Cascadian Therapeutics Reports Topline ONT-380 "Triplet" Data and Outlines Key Development... Jun 14 2016
    Cascadian Therapeutics, Inc. :CASC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 Jun 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)